← Back to home

Chronic urticaria (CU): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (CSU)

Clinical trials for Chronic urticaria (CU): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (CSU) explained in plain language.

Never miss a new study

Get alerted when new Chronic urticaria (CU): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (CSU) trials appear

Sign up with your email to follow new studies for Chronic urticaria (CU): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (CSU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill could tame stubborn hives

Disease control Recruiting now

This study tests a new drug called remibrutinib (a tablet) against a placebo in 44 adults with chronic hives (either spontaneous or triggered by things like pressure or cold). The goal is to see if it reduces symptoms like itching and burning, and how it works in the body. Partic…

Matched conditions: CHRONIC URTICARIA (CU): CHRONIC INDUCIBLE URTICARIA (CINDU) AND CHRONIC SPONTANEOUS URTICARIA (CSU)

Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC

Chronic urticaria (CU): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (CSU)

Get alerted when new Chronic urticaria (CU): chronic inducible urticaria (cindu) and chronic spontaneous urticaria (CSU) trials appear

New pill could tame stubborn hives